2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$91.00+$1.07 (+1.19%)
Price as of Jun 23, 2026 6:33 PM EDT- $4.4BMarket Cap
- 685.41%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$91.00+$1.07 (+1.19%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -145.0M +39.15% | -104.2M +71.97% | -60.6M -271.71% | 35.3M +37.00% | |
Depreciation and Amortization Expense | 167,000 +28.51% | 129,947 -8.98% | 142,772 -32.31% | 210,918 -30.44% | |
Total Operating Expenses | 172.2M +52.02% | 113.3M +71.02% | 66.2M +68.14% | 39.4M +38.92% | |
Operating Profit | -172.2M +52.02% | -113.3M +71.02% | -66.2M +68.14% | -39.4M +38.92% | |
Interest Income | 12.3M +4.50% | 11.8M +51.31% | 7.8M +590.02% | 1.1M +8,399.19% | |
Interest Expense | -2.7M N/A | N/A N/A | -5.3M +152.90% | -2.1M +66.84% | |
Interest Income and Expense and Net | 9.6M -18.44% | 11.8M +380.10% | 2.5M +117.47% | 1.1M +8,399.19% | |
Total Nonoperating Income and Expense | -4.8M -425.97% | 1.5M -39.30% | 2.5M +350.39% | -978,949 -21.64% | |
Income before Taxes | -177.0M +58.39% | -111.8M +75.26% | -63.8M +57.99% | -40.4M +36.36% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | N/A N/A | -63.8M +57.99% | -40.4M +36.36% | |
Net Income from Continuing Operations Applicable to Common | -177.0M +58.39% | -111.8M +75.26% | -63.8M +57.99% | -40.4M +36.36% | |
Basic EPS and Net Income | -3.79 +33.92% | -2.83 +5.20% | -2.69 +1.89% | -2.64 +19.46% | |
Diluted EPS and Net Income | -3.79 +33.92% | -2.83 +5.20% | -2.69 +1.89% | -2.64 +19.46% | |
Basic Weighted Average Shares | 46.8M +18.53% | 39.4M +66.60% | 23.7M +53.58% | 15.4M +15.21% | |
Diluted Weighted Average Shares | 46.8M +18.53% | 39.4M +66.60% | 23.7M +53.58% | 15.4M +15.21% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 165.7M +635.97% | 22.5M -26.57% | 30.7M +24.79% | 24.6M -70.85% | |
Short-Term Investments | 275.8M +29.73% | 212.6M +41.80% | 149.9M +4.10% | 144.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 441.5M +87.79% | 235.1M +30.19% | 180.6M +7.12% | 168.6M +100.02% | |
Total Current Assets | 465.7M +90.40% | 244.6M +28.32% | 190.6M +8.79% | 175.2M +105.26% | |
Accumulated Depreciation | 2.2M +8.39% | 2.0M +6.98% | 1.9M +8.30% | 1.7M +13.98% | |
Property and Plant and Equipment and Net | 499,000 +48.28% | 336,515 +47.09% | 228,782 -12.11% | 260,294 -16.69% | |
Total Long-Term Assets | 349,000 +3.71% | 336,515 +47.09% | 228,782 -12.11% | 260,294 -16.69% | |
Total Assets | 466.6M +90.34% | 245.1M +28.19% | 191.2M +8.83% | 175.7M +104.52% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 44.2M +39.18% | 31.7M +123.58% | 14.2M +106.19% | 6.9M +174.64% | |
Total Long-Term Debt | 321.9M +229.34% | 97.7M +163.87% | 37.0M +5.87% | 35.0M +139.19% | |
Total Long-Term Liabilities | 126.5M +29.40% | 97.8M +162.42% | 37.3M +6.33% | 35.0M +138.59% | |
Total Liabilities | 366.0M +182.62% | 129.5M +151.71% | 51.5M +22.72% | 41.9M +143.81% | |
Retained Earnings | -448.9M +65.12% | -271.9M +69.83% | -160.1M +66.23% | -96.3M +72.18% | |
Total Stockholders Equity | N/A N/A | 115.6M -17.28% | 139.8M +4.48% | 133.8M +94.69% | |
Total Shares Outstanding | 48.2M +29.89% | 37.1M +45.63% | 25.5M +17.72% | 21.7M +45.23% | |
Cash Flow | |||||
Cash from Operating Activities | -153.3M +83.64% | -83.5M +55.11% | -53.8M +49.44% | -36.0M +77.28% | |
Capital Expenditures | 249,000 -0.35% | 249,878 +155.91% | 97,644 -38.50% | 158,768 +93.86% | |
Cash from Investing Activities | -64.1M +1.61% | -63.1M +1,159.32% | -5.0M -96.52% | -144.0M +176,847.58% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 360.6M +160.54% | 138.4M +113.19% | 64.9M -46.05% | 120.3M +29.32% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | N/A N/A | N/A N/A | -34.76% +12.64% | -30.86% -48.47% | |
Return on Equity | N/A N/A | N/A N/A | -46.63% +16.95% | -39.88% -45.85% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 10.55 +36.80% | 7.71 -42.60% | 13.43 -47.24% | 25.46 -25.26% | |
Cash Ratio | 3.75 +428.81% | 0.71 -67.16% | 2.16 -39.48% | 3.57 -89.39% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow